n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Myocardial Ischemia in 4 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnaud, C | 1 |
| Joyeux-Faure, M | 1 |
| Godin-Ribuot, D | 1 |
| Ribuot, C | 1 |
| Shibata, R | 1 |
| Sato, K | 1 |
| Pimentel, DR | 1 |
| Takemura, Y | 1 |
| Kihara, S | 1 |
| Ohashi, K | 1 |
| Funahashi, T | 1 |
| Ouchi, N | 1 |
| Walsh, K | 1 |
| Birkenmeier, K | 1 |
| Staudt, A | 1 |
| Schunck, WH | 1 |
| Janke, I | 1 |
| Labitzke, C | 1 |
| Prange, T | 1 |
| Trimpert, C | 1 |
| Krieg, T | 1 |
| Landsberger, M | 1 |
| Stangl, V | 1 |
| Felix, SB | 1 |
| Shinmura, K | 1 |
| Tang, XL | 1 |
| Wang, Y | 1 |
| Xuan, YT | 1 |
| Liu, SQ | 1 |
| Takano, H | 1 |
| Bhatnagar, A | 1 |
| Bolli, R | 1 |
4 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Myocardial Ischemia
| Article | Year |
|---|---|
COX-2: an in vivo evidence of its participation in heat stress-induced myocardial preconditioning.
Topics: Animals; Blotting, Western; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase | 2003 |
Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Apoptosis; Cells, Cultured; Cyclooxygenase 2; C | 2005 |
COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia.
Topics: Adenosine Triphosphate; Animals; Calcium Signaling; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenas | 2007 |
Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyc | 2000 |